Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA granted a supplemental approval for teriflunomide from Teva Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)